二甲双胍治疗与糖尿病患者升主动脉瘤患病率无关
本研究纳入734例因升主动脉瘤和/或主动脉瓣疾病接受开胸手术的患者,通过问卷自报糖尿病状态和用药情况。结果证实糖尿病与升主动脉瘤患病率呈负相关,但在糖尿病患者中,二甲双胍治疗与升主动脉瘤患病率无差异,不支持二甲双胍对升主动脉瘤形成有保护作用。
要点
- 糖尿病与升主动脉瘤患病率呈负相关(OR 0.243)。
- 糖尿病患者中二甲双胍治疗与升主动脉瘤患病率无差异(OR 1.039)。
- 二甲双胍治疗与较低的高敏C反应蛋白水平相关。
核心结论
- 数据不支持二甲双胍治疗对升主动脉瘤形成具有保护作用。
研究设计与样本
- 研究共纳入734例因升主动脉瘤和/或主动脉瓣疾病接受开胸手术的患者。
- 糖尿病状态和用药情况由患者通过系统问卷自报。
- 主动脉扩张定义为主动脉根部或升主动脉直径≥4.0 cm。
主要发现
- 糖尿病与升主动脉瘤患病率呈负相关:糖尿病患者患病率16%,非糖尿病患者43.9%,OR 0.243,95% CI 0.129-0.460,P < 0.001。
- 糖尿病患者中,接受与未接受二甲双胍治疗者的升主动脉瘤患病率无差异:均为16%,OR 1.039,95% CI 0.26-4.19,P = 0.957。
- 在糖尿病患者中,二甲双胍治疗与较低的高敏C反应蛋白水平相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Metformin therapy has previously been associated with reduced abdominal aortic aneurysm growth rate in diabetic patients and shown to suppress the formation and progression of abdominal aortic aneurysm in normoglycemic mice. Here, we investigated the association between Metformin treatment and prevalence of aneurysm in the ascending aorta (AscAA). METHODS: A total of 734 patients undergoing open-heart surgery for AscAA and/or aortic valve disease were studied. Diabetes status and medication use were self-reported by the patients in a systematic questionnaire. Aortic dilatation was defined as an aortic root or ascending aortic diameter ≥4.0 cm. High-sensitivity C-reactive protein levels were assessed as a measure of systemic inflammation. RESULTS: We could confirm the inverse association between diabetes and AscAA prevalence (16% vs 43.9%, for diabetic and non-diabetic patients, respectively; Odds ratio 0.243; 95% CI, 0.129-0.460, P < 0.001). Furthermore, in diabetic patients, Metformin treatment was associated with lower high-sensitivity C-reactive protein levels. There was, however, no difference in the prevalence of AscAA among diabetic patients with and without Metformin treatment (16% vs 16% for treated and non-treated patients, respectively; OR 1.039; 95% CI 0.26-4.19, P = 0.957). CONCLUSIONS: Our data do not support a protective effect of Metformin therapy in AscAA formation. SUBJ COLLECTION: 161, 173.
引用
- Vignac M, Ntika S, Olsson C, et al. Metformin therapy is not associated with the lower prevalence of ascending aortic aneurysm in diabetic patients. Eur J Cardiothorac Surg. 2022. PMID: 34676406. doi:10.1093/ejcts/ezab435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。